---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-226674"
form_type: "8-K"
ticker: "SANA"
cik: "0001770121"
company_name: "Sana Biotechnology, Inc."
filed_at: "2026-05-15T20:06:25+00:00"
generated_at: "2026-05-15T20:12:19.968384+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Sana Biotechnology sells 21.6M shares for $69M in at-the-market offering

## Summary
- Sold 21,607,878 shares for net proceeds of approx. $69.0 million on May 15, 2026.
- Equity sale conducted under amended and restated sales agreement with TD Securities as agent.
- Offering utilized existing at-the-market facility; no new registration statement filed.

## SEC filing metadata
- accession: 0001193125-26-226674
- form_type: 8-K
- ticker: SANA
- cik: 0001770121
- company_name: Sana Biotechnology, Inc.
- filed_at: 2026-05-15T20:06:25+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1770121/000119312526226674/0001193125-26-226674-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1770121/000119312526226674/d135844d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-226674
- JSON: https://secwatch.observer/filing/0001193125-26-226674.json
- Plain text: https://secwatch.observer/filing/0001193125-26-226674.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.